Health Condition 1: R730- Abnormal glucose
Conditions
Interventions
Intervention1: ICMR-DPCI: The ICMR-DPCI intervention is a fully automated, WhatsApp-based self-management support programme for diabetes prevention. After enrolment, participants receive approximately
Sponsors
Indian Council of Medical Research (ICMR)
Eligibility
Inclusion criteria
Inclusion criteria: - Permanent residents of the selected zone - Indian Diabetes Risk Score (IDRS) greater than 60 and-or Community Based Assessment Checklist (CBAC) score greater than 4 - Individuals with prediabetes with HbA1c from 5.7 to 6.4 - Willingness to provide informed consent - Ownership of smartphone with internet access or we will include those who can reliably access a smartphone via a family member for the intervention period. - Willing and able to answer calls and read multimedia messages in Tamil, Hindi, or English as part of the study.
Exclusion criteria
Exclusion criteria: - Patients with type 1 diabetes mellitus and type 2 diabetes mellitus (self-reported) for prediabetes (objective) - Patients with learning difficulties or vision and/or hearing impairments without a caregiver, making it impossible to use a mobile phone - Malignancy or life-threatening disease with death probable in 4 years - Inability or unwillingness of individual or legal guardian to give written informed consent - Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the progression to diabetes which is defined as HbA1c greater than or equal to 6.5 percent at any follow up visit or in another care setting with American Diabetes Association (ADA) criteria for diagnosis of diabetes. Timepoint: Baseline, 6 months and 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes include the proportion of participants achieving HbA1c less than or equal to 6.4 percent, blood pressure, blood lipids, body weight, dietary intake, physical activity, acceptability of intervention and sedentary behaviour measured using valid and reliable self-report questionnaires.Timepoint: Baseline and follow up at 12 months. | — |
Countries
India
Contacts
Public ContactDr Joshua Chadwick
ICMR-National Institute of Epidemiology, Chennai
Outcome results
None listed